Production (Stage)
Avenue Therapeutics, Inc.
ATXI
$0.2088
-$0.0113-5.13%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.64% | 45.49% | 1,513.04% | 213.11% | -61.22% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -20.69% | 16.42% | 55.56% | 0.00% | -41.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.58% | 44.43% | 422.91% | 199.40% | -60.81% |
|
|
|||||
| Total Current Assets | 8.58% | 44.43% | 422.91% | 199.40% | -60.81% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 8.58% | 44.43% | 422.91% | 199.40% | -60.81% |
|
|
|||||
| Total Accounts Payable | -34.89% | -24.94% | 17.32% | 18.40% | 77.01% |
| Total Accrued Expenses | 146.29% | 138.76% | -75.34% | -63.75% | -92.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -99.76% | -97.27% | -99.12% | -99.20% | -92.78% |
| Total Other Current Liabilities | -99.76% | -97.27% | -99.12% | -99.20% | -92.78% |
| Total Current Liabilities | -10.62% | -31.77% | -80.63% | -85.14% | -86.68% |
|
|
|||||
| Total Current Liabilities | -10.62% | -31.77% | -80.63% | -85.14% | -86.68% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -10.62% | -31.77% | -80.63% | -85.14% | -86.68% |
|
|
|||||
| Common Stock & APIC | 10.03% | 13.91% | 17.89% | 18.40% | 13.24% |
| Retained Earnings | -9.62% | -12.81% | -10.34% | -6.37% | -8.15% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 23.77% | 76.80% | 171.51% | 189.28% | 295.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.77% | 76.80% | 171.51% | 189.28% | 295.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -25.59% | -1.40% | -9.86% | -15.68% | -33.05% |
| Total Equity | 22.87% | 183.79% | 136.53% | 162.27% | 187.99% |
|
|
|||||